Bendroflumethiazide

Država: Nova Zelandija

Jezik: angleščina

Source: Medsafe (Medicines Safety Authority)

Aktivna sestavina:

Bendroflumethiazide 2.5mg;  ;  

Dostopno od:

Ipca Pharma (NZ) Pty Limited

INN (mednarodno ime):

Bendroflumethiazide 2.5 mg

Odmerek:

2.5 mg

Farmacevtska oblika:

Tablet

Sestava:

Active: Bendroflumethiazide 2.5mg     Excipient: Lactose Purified talc Starch Stearic acid

Enote v paketu:

Blister pack, PVC/PVDC, 14 tablets

Razred:

Prescription

Tip zastaranja:

Prescription

Izdeluje:

Ipca Laboratories Limited

Terapevtske indikacije:

Bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.

Povzetek izdelek:

Package - Contents - Shelf Life: Blister pack, PVC/PVDC - 14 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC - 28 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 500 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 1000 tablets - 24 months from date of manufacture stored at or below 25°C

Datum dovoljenje:

2006-06-28